Medication info
Rosuvastatin Calcium 20 mg Tablet

Rosuvastatin Calcium 20 mg Tablet

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201604060 · Approved 2016.06.29 · Insurance code 073001300

Summary

Main use
Treatment of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
Who uses it
Adults
Adult dosage
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary artery disease
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
  • stroke
  • myocardial infarction
View approved original text

This medication is used as an adjunct for patients with primary hypercholesterolemia and mixed dyslipidemia who are inadequately controlled by diet and exercise. It is also used in conjunction with dietary changes or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia to enhance effectiveness. It helps to lower total cholesterol and LDL-cholesterol levels to target levels, slowing the progression of atherosclerosis. It is also utilized as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. Additionally, this drug reduces the risk of cardiovascular diseases associated with stroke, myocardial infarction, and arterial revascularization in high-risk patients with elevated high-sensitivity C-reactive protein levels. Overall, it is used to improve cardiovascular health.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Precautions

This medication should not be used in certain patients. For example, individuals who are allergic to this medication, those with active liver disease, muscle disorders, and patients with severe renal impairment should not take this drug. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing potential should use appropriate contraceptive methods to minimize the possibility of pregnancy. Moreover, patients at high risk for muscle disorders should avoid high doses. This drug contains lactose, so caution is required for patients with lactose intolerance. Patients with poor liver function or excessive alcohol intake should have regular liver function tests before and during treatment with this medication. Those with thyroid dysfunction or nephrotic syndrome should treat their underlying conditions before taking this drug. Muscle-related side effects such as myalgia, myopathy, and rhabdomyolysis have been reported; thus, if there are any unusual muscle symptoms, immediate medical consultation is necessary. Particularly, if muscle pain, weakness, or cramps occur, blood tests should be performed to check for muscle damage, and discontinuation of the medication may be warranted if necessary. This medication can interact with certain drugs; therefore, if other drugs are being taken, healthcare providers should be informed. Particularly, co-administration with drugs that affect hepatic metabolism may increase the blood concentration of this drug, raising the risk of side effects. The safety of this medication has not been established in pregnant or breastfeeding women; hence, its use should be avoided, and women planning to become pregnant should consult their healthcare provider prior to use. There is no specific antidote for overdose; management should focus on symptomatic treatment along with liver function and muscle enzyme tests. This medication is known not to significantly affect the ability to drive or operate machinery, but caution is required as symptoms such as dizziness may occur. Finally, if severe skin reactions or allergic symptoms appear during treatment with this medication, it should be discontinued immediately and healthcare providers should be consulted.

Side effects

Hypersensitivity reactions, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and light, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.